Combination products provide new avenues for the development of improved drug-drug, drug-device products, as well as generating opportunities for companies to leverage their existing products & patent life.  This forum will focus on the development challenges, commercial and partnering strategies, as well as the market implications of combination products.

Published in CoreRx News
Monday, 22 February 2010 00:00

Combination Products should be considered

According to Pharmaceutical Technology, there has been a surge in the number of combination product (i.e. where a drug product is combined with a medical device) launches in recent years and this trend is set to continue as more companies seek to extend the life of existing branded medicines.

Sunday, 19 June 2011 00:00

CoreRx Named to Tampa’s 2011 Fast 50

CoreRx, fast becoming a world-recognized leader in early drug contract development, was announced today as one of Tampa Bay’s Fast 50  companies. The Tampa Bay Business Journal’s Fast 50 is a list of the  fastest growing privately held companies in Tampa Bay over a span of  three years. Last year, CoreRx was recognized as the  6th fastest growing company in the Tampa Bay region.

Published in CoreRx News

source logos